A
ANIP
Ani Pharmaceutic
70.52
-0.95-1.32%Opening12:35 09/11 EDT
OPEN/PREV CLOSE71.53/71.46
TODAY RANGE69.58-71.92
VOL413.61K
MARKET CAP1.61B
52 WEEK RANGE69.58-99.50
AVG VOL (3M)347.39K
% TURNOVER1.43%
TURNOVER--
P/E (TTM)15.22
% RANGE3.27%
EPS(TTM)4.611
P/E(FORWARD)14.14
P/B2.700
BVPS26.00
DIVIDEND--
P/S1.788
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.42B
SHARES OUTSTANDING22.96M
NEXT EARNINGS11/05-11/09
FREE FLOAT20.28M
LOT SIZE1
EX-DATE07/18/2013
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
ANI Pharmaceuticals initiated with an Outperform at Leerink
TipRanks·08/26 08:15
ANI Pharmaceuticals (ANIP) Gets a Buy from Barclays
TipRanks·08/24 11:48
ANI Pharmaceuticals reshapes board to advance rare disease strategy
Dow Jones·08/24 10:55
Press Release: ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
TipRanks·08/19 00:22
ANI Pharmaceuticals Earnings Call Signals Growth Momentum
NASDAQ·08/14 17:15
Should You Buy ANIP as Low Valuation Meets Cortrophin Execution Risk?
NASDAQ·08/14 17:12
ANIP's Cortrophin Guidance Cut Raises the Bar for Second-Half Growth
Benzinga·08/10 14:39
These Analysts Slash Their Forecasts On ANI Pharmaceuticals After Q2 Results
Dow Jones·08/10 14:17
ANI Pharmaceuticals Price Target Cut to $119.00/Share From $124.00 by Guggenheim
Dow Jones·08/10 14:17
ANI Pharmaceuticals Is Maintained at Buy by Guggenheim
Benzinga·08/10 14:07
Guggenheim Maintains Buy on ANI Pharmaceuticals, Lowers Price Target to $119
Dow Jones·08/10 12:35
ANI Pharmaceuticals Is Maintained at Hold by Canaccord Genuity
Same Industry
Name/Symbol
Change%
Price